rthbs1 (MedChemExpress)
Structured Review
Rthbs1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/thbs1%2C+human/THBS1%2C+Human/pm41679183-80-11-15
Average 94 stars, based on 1 article reviews
Images
Related Articles
Recombinant:Article Title: Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis. Article Snippet: (FBS, Gibco) at 37 °C in an incubator with a humidified atmosphere of 5% O2 and 5% CO2. For thrombospondin 1 treatment, RAW 264.7 cells were treated with diverse doses of thrombospondin 1 Control:Article Title: Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis. Article Snippet: (FBS, Gibco) at 37 °C in an incubator with a humidified atmosphere of 5% O2 and 5% CO2. For thrombospondin 1 treatment, RAW 264.7 cells were treated with diverse doses of thrombospondin 1 Concentration Assay:Article Title: Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis. Article Snippet: (FBS, Gibco) at 37 °C in an incubator with a humidified atmosphere of 5% O2 and 5% CO2. For thrombospondin 1 treatment, RAW 264.7 cells were treated with diverse doses of thrombospondin 1 Cell Culture:Article Title: Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis. Article Snippet: (FBS, Gibco) at 37 °C in an incubator with a humidified atmosphere of 5% O2 and 5% CO2. For thrombospondin 1 treatment, RAW 264.7 cells were treated with diverse doses of thrombospondin 1 Activation Assay:Article Title: Single-Cell Spatial Transcriptomics Unveils Platelet-Fueled Cycling Macrophages for Kidney Fibrosis. Article Snippet: (FBS, Gibco) at 37 °C in an incubator with a humidified atmosphere of 5% O2 and 5% CO2. For thrombospondin 1 treatment, RAW 264.7 cells were treated with diverse doses of thrombospondin 1 |

![Down-regulation of lactate production and histone lactylation is driven by mitophagy activation. (A) Lactate levels of the young and aged NP cells treated with or without TJ0113 (5 μM, 48 h; n = 5) after knocking down MCL1. (B) Western blot analysis of PAN-KLA in young and aged NP cells treated with or without TJ0113 (5 μM, 48 h) after knocking down MCL1. (C and D) Western blot analysis of lysine lactylation markers (H3K9la, H3K14la, H3K18la, H4K12la) treated with TJ0113 or not (5 μM, 48 h). Histone H3/H4 served as loading controls. (E) Heatmap depicting H3K18la genomic occupancy profiles [±3 kb flanking transcription start sites (TSSs)] treated with TJ0113 or not (5 μM, 48 h). Genes are ranked vertically by descending H3K18la signal intensity. (F) Comparative pie charts showing genome-wide differential H3K18la distribution patterns at annotated genomic regions in aged NP cells treated with TJ0113 (5 μM, 48 h) compared to untreated controls. (G) KEGG enrichment analysis of H3K18la-marked genes. (H) Venn diagram depicting genes down-regulated in RNA-seq analysis of aged NP cells treated with TJ0113 (5 μM, 48 h) compared to untreated controls and the down-regulated target genes bound by H3K18la under identical treatment conditions. (I) Normalized read densities for H3K18la at the <t>THBS1</t> genes. (J) ChIP-qPCR assay in aged NP cells. Results represent the mean ± SD of at least 3 independent experiments. Significance levels are shown within the graphs.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6853/pmc12586853/pmc12586853__research.0957.fig.005.jpg)
